213 related articles for article (PubMed ID: 7523731)
1. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer.
Catalona WJ; Smith DS
J Urol; 1994 Nov; 152(5 Pt 2):1837-42. PubMed ID: 7523731
[TBL] [Abstract][Full Text] [Related]
2. Can radical prostatectomy alter the progression of poorly differentiated prostate cancer?
Ohori M; Goad JR; Wheeler TM; Eastham JA; Thompson TC; Scardino PT
J Urol; 1994 Nov; 152(5 Pt 2):1843-9. PubMed ID: 7523732
[TBL] [Abstract][Full Text] [Related]
3. The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy.
Trapasso JG; deKernion JB; Smith RB; Dorey F
J Urol; 1994 Nov; 152(5 Pt 2):1821-5. PubMed ID: 7523728
[TBL] [Abstract][Full Text] [Related]
4. Correlation of pathologic findings with progression after radical retropubic prostatectomy.
Epstein JI; Pizov G; Walsh PC
Cancer; 1993 Jun; 71(11):3582-93. PubMed ID: 7683970
[TBL] [Abstract][Full Text] [Related]
5. Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C).
Epstein JI; Walsh PC; Brendler CB
J Urol; 1994 Nov; 152(5 Pt 2):1721-9. PubMed ID: 7523719
[TBL] [Abstract][Full Text] [Related]
6. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years.
Walsh PC; Partin AW; Epstein JI
J Urol; 1994 Nov; 152(5 Pt 2):1831-6. PubMed ID: 7523730
[TBL] [Abstract][Full Text] [Related]
7. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
Magheli A; Rais-Bahrami S; Peck HJ; Walsh PC; Epstein JI; Trock BJ; Gonzalgo ML
J Urol; 2007 Oct; 178(4 Pt 1):1311-5. PubMed ID: 17698095
[TBL] [Abstract][Full Text] [Related]
8. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.
Freedland SJ; Presti JC; Terris MK; Kane CJ; Aronson WJ; Dorey F; Amling CL;
J Urol; 2003 Jun; 169(6):2129-35. PubMed ID: 12771734
[TBL] [Abstract][Full Text] [Related]
9. Location of positive surgical margins after retropubic, perineal, and laparoscopic radical prostatectomy for organ-confined prostate cancer.
Salomon L; Anastasiadis AG; Levrel O; Katz R; Saint F; de la Taille A; Cicco A; Vordos D; Hoznek A; Chopin D; Abbou CC
Urology; 2003 Feb; 61(2):386-90. PubMed ID: 12597953
[TBL] [Abstract][Full Text] [Related]
10. Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results.
Catalona WJ; Smith DS
J Urol; 1998 Dec; 160(6 Pt 2):2428-34. PubMed ID: 9817397
[TBL] [Abstract][Full Text] [Related]
11. Effect of age on biochemical recurrence after radical prostatectomy.
Ozden C; Aktas BK; Bulut S; Erbay G; Tagci S; Gokkaya CS; Baykam MM; Memis A
Kaohsiung J Med Sci; 2017 Feb; 33(2):91-95. PubMed ID: 28137417
[TBL] [Abstract][Full Text] [Related]
12. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
Haukaas SA; Halvorsen OJ; Daehlin L; Hostmark J; Akslen LA
BJU Int; 2006 Jan; 97(1):51-5. PubMed ID: 16336328
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.
Smith JA; Chan RC; Chang SS; Herrell SD; Clark PE; Baumgartner R; Cookson MS
J Urol; 2007 Dec; 178(6):2385-9; discussion 2389-90. PubMed ID: 17936849
[TBL] [Abstract][Full Text] [Related]
14. Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy.
Eggener SE; Roehl KA; Smith ND; Antenor JA; Han M; Catalona WJ
J Urol; 2005 Apr; 173(4):1150-5. PubMed ID: 15758725
[TBL] [Abstract][Full Text] [Related]
15. Limited value of perineural invasion in radical prostatectomy specimens as a predictor of biochemical recurrence in Japanese men with clinically localized prostate cancer.
Miyake H; Sakai I; Harada K; Eto H; Hara I
Hinyokika Kiyo; 2005 Apr; 51(4):241-6. PubMed ID: 15912782
[TBL] [Abstract][Full Text] [Related]
16. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
17. Radical prostatectomy for prostate cancer: the perineal approach increases the risk of surgically induced positive margins and capsular incisions.
Boccon-Gibod L; Ravery V; Vordos D; Toublanc M; Delmas V; Boccon-Gibod L
J Urol; 1998 Oct; 160(4):1383-5. PubMed ID: 9751359
[TBL] [Abstract][Full Text] [Related]
18. Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.
Magheli A; Rais-Bahrami S; Carter HB; Peck HJ; Epstein JI; Gonzalgo ML
J Urol; 2007 Oct; 178(4 Pt 1):1277-80; discussion 1280-1. PubMed ID: 17698121
[TBL] [Abstract][Full Text] [Related]
19. Does capsular incision at radical retropubic prostatectomy affect disease-free survival in otherwise organ-confined prostate cancer?
Barocas DA; Han M; Epstein JI; Chan DY; Trock BJ; Walsh PC; Partin AW
Urology; 2001 Nov; 58(5):746-51. PubMed ID: 11711353
[TBL] [Abstract][Full Text] [Related]
20. Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancer.
Carini M; Masieri L; Minervini A; Lapini A; Serni S
Eur Urol; 2008 Mar; 53(3):554-61. PubMed ID: 17683854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
